AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 237: F232-F240, 1979;
0363-6127/79 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, M. J.
Right arrow Articles by Manning, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, M. J., Jr
Right arrow Articles by Manning, R. D., Jr

AJP - Renal Physiology, Vol 237, Issue 3 232-F240, Copyright © 1979 by American Physiological Society

ARTICLES

Acute and chronic effects of vasopressin on blood pressure, electrolytes, and fluid volumes

M. J. Smith Jr, M. J. Cowley Jr, A. C. Guyton and R. D. Manning Jr

Physiological levels of arginine vasopressin (AVP) were continuously infused 24 h/day into six dogs for periods ranging from 7 to 34 days. The acute and chronic responses of the mean arterial pressure (MAP), body fluid volumes, renal function indices, plasma electrolyte concentrations, plasma renin activity, and urinary electrolyte and water excretion rates were measured. MAP was unaffected acutely but rose significantly to a peak on day 9 before declining toward control. MAP was significantly and positively correlated with the plasma volume, but had a diphasic correlation with the plasma sodium concentration and the change in total body sodium. The plasma sodium concentration reached a relatively stable plateau that was maintained in spite of large changes in total body water. We conclude that AVP produces only a transient hypervolemic hypertension; that AVP is a natriuretic agent, either directly or indirectly, both acutely and chronically; and that chronically it is a more potent controller of the plasma sodium concentration than of the total body water except in extreme cases.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
P. M. O'Connor and A. W. Cowley Jr.
Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V2 receptor activation of the phosphoinositide pathway
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F526 - F532.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Tachikawa, H. Yokoi, H. Nagasaki, H. Arima, T. Murase, Y. Sugimura, Y. Miura, M. Hirabayashi, and Y. Oiso
Altered cardiovascular regulation in arginine vasopressin-overexpressing transgenic rat
Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1161 - E1166.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. W. Cowley Jr., T. Mori, D. Mattson, and A.-P. Zou
Role of renal NO production in the regulation of medullary blood flow
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1355 - R1369.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online